Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062568 · ClinicalTrials.gov registry record · Phase 3
The Adrenal Contribution to Androgen Production in Girls During Puberty
A Phase 3 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT01062568 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 50 participants.
The verdict
NCT01062568, a Phase 3 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
In girls with elevated androgens the precise source of androgen excess throughout puberty and early adolescence has not been carefully examined. The investigators propose to examine whether the adrenal gland produces the majority of androgens during puberty by studying the differences in androgen responses to adrenocorticotropin hormone (ACTH) administration in normal weight (NW) and obese (OB) girls ages 7-18. The investigators' analyses will compare steroid changes before and 60 min after ACTH administration in NW and OB girls.
Interventions
- DRUG Dexamethasone
- DRUG Adrenocorticotropin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062568
The ClinicalTrials.gov registry entry for NCT01062568 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT01062568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062568 about?
NCT01062568 is a clinical study titled "The Adrenal Contribution to Androgen Production in Girls During Puberty". In girls with elevated androgens the precise source of androgen excess throughout puberty and early adolescence has not been carefully examined. The investigators propose to examine whether the adrenal gland produces the majority of androgens during puberty by studying the differences in androgen re...
What is the current status of trial NCT01062568?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2010-02. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01062568?
The interventions under investigation include: Dexamethasone (DRUG), Adrenocorticotropin (DRUG).
Who is sponsoring clinical trial NCT01062568?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.